Clinical Characteristics of 46,XX Males with Congenital Adrenal Hyperplasia

Yıl: 2021 Cilt: 13 Sayı: 2 Sayfa Aralığı: 180 - 186 Metin Dili: İngilizce DOI: 10.4274/jcrpe.galenos.2020.2020.0216 İndeks Tarihi: 15-11-2021

Clinical Characteristics of 46,XX Males with Congenital Adrenal Hyperplasia

Öz:
Objective: To retrospectively evaluate the follow-up data in patients with 46,XX congenital adrenal hyperplasia (CAH) who were raisedmale.Methods: A national database was created. The data of patients were asked to be recorded in the data form.Results: The median (range) age of diagnosis was three (0.1-18.3) years in 44 patients. Twenty nine cases were diagnosed after the ageof two years. Most (95.4%) cases were stage 4-5 virilized. Hysterectomy and bilateral salpingoopherectomy, at a median age of 7.25(2.4-25.3) years, was performed in 35 cases. Testicular prostheses were placed in 11 (25%) cases at a median age of 11.2 (2.8-17) years.The median final height was 149.2 (132.8-172) cms in 38 patients, including simple virilizing (n=18), salt-wasting (n=6), and 11-betahydroxylase (n=12). Of the 16 patients above the age of eighteen, university education was completed in 25%.Conclusion: It was seen that most (65.9%) of the 46,XX CAH cases raised male were diagnosed after two years of age. In these cases,hysterectomy and bilateral salpingoopherectomy, genital corrective surgeries and testicular prosthesis operations were performed in avery wide age rage.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Hughes IA, Houk C, Ahmed SF, Lee PA. Consensus statement on management of intersex disorders. J Pediatr Urol 2006;2:148-162. Epub 2006 May 23
  • 2. Furtado PS, Moraes F, Lago R, Barros LO, Toralles MB, Barroso U Jr. Gender dysphoria associated with disorders of sex development. Nat Rev Urol 2012;9:620-627. Epub 2012 Oct 9
  • 3. Apóstolos RAC, Canguçu-Campinho AK, Lago R, Costa ACS, Oliveira LMB, Toralles MB, Barroso U Jr. Gender identity and sexual function in 46, XX patients with congenital adrenal hyperplasia raised as males. Arch Sex Behav 2018;47:2491-2496. Epub 2018 Oct 5
  • 4. Lee PA, Houk CP, Husmann DA. Should male gender assignment be considered in the markedly virilized patient with 46, XX and congenital adrenal hyperplasia? J Urol 2010;184:1786-1792. Epub 2010 Aug 21
  • 5. Lee PA, Houk CP. Review of outcome information in 46,XX patients with congenital adrenal hyperplasia assigned/reared male: what does it say about gender assignment? Int J Pediatr Endocrinol 2010;2010:982025. Epub 2010 Dec 21
  • 6. Houk CP, Lee PA. Approach to assigning gender in 46, XX congenital adrenal hyperplasia with male external genitalia: replacing dogmatism with pragmatism. J Clin Endocrinol Metab 2010;95:4501-4508.
  • 7. Dessens AB, Slijper FM, Drop SL. Gender dysphoria and gender change in chromosomal females with congenital adrenal hyperplasia. Arch Sex Behav 2005;34:389-397.
  • 8. Daae E, Feragen KB, Waehre A, Nermoen I, Falhammar H. Sexual orientation in individuals with congenital adrenal hyperplasia: A systematic review. Front Behav Neurosci 2020;14:38.
  • 9. Prader A. Der Genitalbefund beim Pseudohermaphroditismus femininus des kongenitalen adrenogenitalen Syndroms; Morphologie, Häufigkeit, Entwicklung und Vererbung der verschiedenen Genitalformen [Genital findings in the female pseudo-hermaphroditism of the congenital adrenogenital syndrome; morphology, frequency, development and heredity of the different genital forms]. Helv Paediatr Acta 1954;9:231- 248.
  • 10. Sharma S, Gupta DK. Male genitoplasty for 46, XX congenital adrenal hyperplasia patients presenting late and reared as males. Indian J Endocrinol Metab 2012;16:935-938.
  • 11. Woelfle J, Hoepffner W, Sippell WG, Brämswig JH, Heidemann P, Deiss D, Bökenkamp A, Roth C, Irle U, Wollmann HA, Zachmann M, Kubini K, Albers N. Complete virilization in congenital adrenal hyperplasia: Clinical course, medical management and disease-related complications. Clin Endocrinol (Oxf) 2002;56:231-238.
  • 12. Chowdhury TK, Laila K, Hutson JM, Banu T. Male gender identity in children with 46, XX DSD with congenital adrenal hyperplasia after delayed presentation in mid-childhood. J Pediatr Surg 2015;50:2060- 2062. Epub 2015 Aug 28
  • 13. Bin-Abbas B, Al-Humaida D, Al-Sagheir A, Qasem E, Almohanna M, Alzahrani AS. Divergent gender identity in three siblings with 46, XX karyotype and severely virilizing congenital adrenal hyperplasia caused by a novel CYP11B1 mutation. Endocr Pract 2014;20:191-197.
  • 14. Dasgupta R, Schnitzer JJ, Hendren WH, Donahoe PK. Congenital adrenal hyperplasia: Surgical considerations required to repair a 46, XX patient raised as a boy. J Pediatr Surg 2003;38:1269-1273.
  • 15. Khattab A, Yau M, Qamar A, Gangishetti P, Barhen A, Al-Malki S, Mistry H, Anthony W, Toralles MB, New MI. Long term outcomes in 46, XX adult patients with congenital adrenal hyperplasia reared as males. J Steroid Biochem Mol Biol 2017;165:12-17. Epub 2016 Apr 25
  • 16. Gürbüz F, Alkan M, Çelik G, Bişgin A, Çekin N, Ünal İ, Topaloğlu AK, Zorludemir Ü, Avcı A, Yüksel B. Gender identity and assignment recommendations in disorders of sex development patients: 20 years’experience and challenges. J Clin Res Pediatr Endocrinol 2020;12:347-357. Epub 2020 Mar 26
  • 17. Çetinkaya M, Özen S, Uslu S, Gönç N, Acunas B, Akıncı A, Satar M, Berberoğlu M. Diagnostic and therapeutic approach in newborns with ambiguous genital with disorder of sex development: consensus report of Turkish Neonatal and Pediatric Endocrinology and Diabetes Societies. Turk Pediatri Ars 2018;53(Suppl 1):198-208.
  • 18. Stikkelbroeck NM, Van’t Hof-Grootenboer BA, Hermus AR, Otten BJ, Van’t Hof MA. Growth inhibition by glucocorticoid treatment in salt wasting 21-hydroxylase deficiency in early infancy and (pre) puberty. J Clin Endocrinol Metab 2003;88:3525-3530.
  • 19. Muthusamy K, Elamin MB, Smushkin G, Murad MH, Lampropulos JF, Elamin KB, Abu Elnour NO, Gallegos-Orozco JF, Fatourechi MM, Agrwal N, Lane MA, Albuquerque FN, Erwin PJ, Montori VM. Clinical review: adult height in patients with congenital adrenal hyperplasia: a systematic review and metaanalysis. J Clin Endocrinol Metab 2010;95:4161-4172.
  • 20. Bretones P, Riche B, Pichot E, David M, Roy P, Tardy V, Kassai B, Gaillard S, Bernoux D, Morel Y, Chatelain P, Nicolino M, Cornu C; French Collaborative CAH Growth Study Group. Growth curves for congenital adrenal hyperplasia from a national retrospective cohort. J Pediatr Endocrinol Metab 2016;29:1379-1388.
  • 21. Han TS, Conway GS, Willis DS, Krone N, Rees DA, Stimson RH, Arlt W, Walker BR, Ross RJ; United Kingdom Congenital Adrenal Hyperplasia Adult Study Executive (CaHASE). Relationship between final height and health outcomes in adults with congenital adrenal hyperplasia: United Kingdom congenital adrenal hyperplasia adult study executive (CaHASE). J Clin Endocrinol Metab 2014;99:1547-1555. Epub 2014 May 30
  • 22. Bonfig W, Bechtold S, Schmidt H, Knorr D, Schwarz HP. Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty. J Clin Endocrinol Metab 2007;92:1635-1639. Epub 2007 Feb 13
  • 23. Javed A, Lteif A, Kumar S. Update on treatment strategies for optimization of final adult height in children with congenital adrenal hyperplasia. Pediatr Endocrinol Rev 2012;10:164-173.
APA SAVAS ERDEVE S, aycan z, Çetinkaya S, Öztürk A, Bas F, Poyrazoglu S, Darendeliler F, Özsu E, siklar z, demiral m, unal e, Ozbek M, gürbüz f, yuksel b, Evliyaoğlu O, akyurek n, berberoglu m (2021). Clinical Characteristics of 46,XX Males with Congenital Adrenal Hyperplasia. , 180 - 186. 10.4274/jcrpe.galenos.2020.2020.0216
Chicago SAVAS ERDEVE SENAY,aycan zehra,Çetinkaya Semra,Öztürk Ayşe Pınar,Bas Firdevs,Poyrazoglu Sukran,Darendeliler Feyza,Özsu Elif,siklar zeynep,demiral meliha,unal edip,Ozbek Mehmet Nuri,gürbüz fatih,yuksel bilgin,Evliyaoğlu Olcay,akyurek nesibe,berberoglu merih Clinical Characteristics of 46,XX Males with Congenital Adrenal Hyperplasia. (2021): 180 - 186. 10.4274/jcrpe.galenos.2020.2020.0216
MLA SAVAS ERDEVE SENAY,aycan zehra,Çetinkaya Semra,Öztürk Ayşe Pınar,Bas Firdevs,Poyrazoglu Sukran,Darendeliler Feyza,Özsu Elif,siklar zeynep,demiral meliha,unal edip,Ozbek Mehmet Nuri,gürbüz fatih,yuksel bilgin,Evliyaoğlu Olcay,akyurek nesibe,berberoglu merih Clinical Characteristics of 46,XX Males with Congenital Adrenal Hyperplasia. , 2021, ss.180 - 186. 10.4274/jcrpe.galenos.2020.2020.0216
AMA SAVAS ERDEVE S,aycan z,Çetinkaya S,Öztürk A,Bas F,Poyrazoglu S,Darendeliler F,Özsu E,siklar z,demiral m,unal e,Ozbek M,gürbüz f,yuksel b,Evliyaoğlu O,akyurek n,berberoglu m Clinical Characteristics of 46,XX Males with Congenital Adrenal Hyperplasia. . 2021; 180 - 186. 10.4274/jcrpe.galenos.2020.2020.0216
Vancouver SAVAS ERDEVE S,aycan z,Çetinkaya S,Öztürk A,Bas F,Poyrazoglu S,Darendeliler F,Özsu E,siklar z,demiral m,unal e,Ozbek M,gürbüz f,yuksel b,Evliyaoğlu O,akyurek n,berberoglu m Clinical Characteristics of 46,XX Males with Congenital Adrenal Hyperplasia. . 2021; 180 - 186. 10.4274/jcrpe.galenos.2020.2020.0216
IEEE SAVAS ERDEVE S,aycan z,Çetinkaya S,Öztürk A,Bas F,Poyrazoglu S,Darendeliler F,Özsu E,siklar z,demiral m,unal e,Ozbek M,gürbüz f,yuksel b,Evliyaoğlu O,akyurek n,berberoglu m "Clinical Characteristics of 46,XX Males with Congenital Adrenal Hyperplasia." , ss.180 - 186, 2021. 10.4274/jcrpe.galenos.2020.2020.0216
ISNAD SAVAS ERDEVE, SENAY vd. "Clinical Characteristics of 46,XX Males with Congenital Adrenal Hyperplasia". (2021), 180-186. https://doi.org/10.4274/jcrpe.galenos.2020.2020.0216
APA SAVAS ERDEVE S, aycan z, Çetinkaya S, Öztürk A, Bas F, Poyrazoglu S, Darendeliler F, Özsu E, siklar z, demiral m, unal e, Ozbek M, gürbüz f, yuksel b, Evliyaoğlu O, akyurek n, berberoglu m (2021). Clinical Characteristics of 46,XX Males with Congenital Adrenal Hyperplasia. Journal of Clinical Research in Pediatric Endocrinology, 13(2), 180 - 186. 10.4274/jcrpe.galenos.2020.2020.0216
Chicago SAVAS ERDEVE SENAY,aycan zehra,Çetinkaya Semra,Öztürk Ayşe Pınar,Bas Firdevs,Poyrazoglu Sukran,Darendeliler Feyza,Özsu Elif,siklar zeynep,demiral meliha,unal edip,Ozbek Mehmet Nuri,gürbüz fatih,yuksel bilgin,Evliyaoğlu Olcay,akyurek nesibe,berberoglu merih Clinical Characteristics of 46,XX Males with Congenital Adrenal Hyperplasia. Journal of Clinical Research in Pediatric Endocrinology 13, no.2 (2021): 180 - 186. 10.4274/jcrpe.galenos.2020.2020.0216
MLA SAVAS ERDEVE SENAY,aycan zehra,Çetinkaya Semra,Öztürk Ayşe Pınar,Bas Firdevs,Poyrazoglu Sukran,Darendeliler Feyza,Özsu Elif,siklar zeynep,demiral meliha,unal edip,Ozbek Mehmet Nuri,gürbüz fatih,yuksel bilgin,Evliyaoğlu Olcay,akyurek nesibe,berberoglu merih Clinical Characteristics of 46,XX Males with Congenital Adrenal Hyperplasia. Journal of Clinical Research in Pediatric Endocrinology, vol.13, no.2, 2021, ss.180 - 186. 10.4274/jcrpe.galenos.2020.2020.0216
AMA SAVAS ERDEVE S,aycan z,Çetinkaya S,Öztürk A,Bas F,Poyrazoglu S,Darendeliler F,Özsu E,siklar z,demiral m,unal e,Ozbek M,gürbüz f,yuksel b,Evliyaoğlu O,akyurek n,berberoglu m Clinical Characteristics of 46,XX Males with Congenital Adrenal Hyperplasia. Journal of Clinical Research in Pediatric Endocrinology. 2021; 13(2): 180 - 186. 10.4274/jcrpe.galenos.2020.2020.0216
Vancouver SAVAS ERDEVE S,aycan z,Çetinkaya S,Öztürk A,Bas F,Poyrazoglu S,Darendeliler F,Özsu E,siklar z,demiral m,unal e,Ozbek M,gürbüz f,yuksel b,Evliyaoğlu O,akyurek n,berberoglu m Clinical Characteristics of 46,XX Males with Congenital Adrenal Hyperplasia. Journal of Clinical Research in Pediatric Endocrinology. 2021; 13(2): 180 - 186. 10.4274/jcrpe.galenos.2020.2020.0216
IEEE SAVAS ERDEVE S,aycan z,Çetinkaya S,Öztürk A,Bas F,Poyrazoglu S,Darendeliler F,Özsu E,siklar z,demiral m,unal e,Ozbek M,gürbüz f,yuksel b,Evliyaoğlu O,akyurek n,berberoglu m "Clinical Characteristics of 46,XX Males with Congenital Adrenal Hyperplasia." Journal of Clinical Research in Pediatric Endocrinology, 13, ss.180 - 186, 2021. 10.4274/jcrpe.galenos.2020.2020.0216
ISNAD SAVAS ERDEVE, SENAY vd. "Clinical Characteristics of 46,XX Males with Congenital Adrenal Hyperplasia". Journal of Clinical Research in Pediatric Endocrinology 13/2 (2021), 180-186. https://doi.org/10.4274/jcrpe.galenos.2020.2020.0216